OBIO

Orchestra BioMed Holdings, Inc. Ordinary Shares

4.01

USD

OBIO Earnings Reports

Positive Surprise Ratio

OBIO beat 9 of 11 last estimates.

82%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Orchestra BioMed Holdings, Inc. Ordinary Shares earnings per share and revenue

On Nov 10, 2025, OBIO reported earnings of -0.40 USD per share (EPS) for Q3 25, beating the estimate of -0.44 USD, resulting in a 9.83% surprise. Revenue reached 861.00 thousand, compared to an expected 772.75 thousand, with a 11.42% difference. The market reacted with a +8.47% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Orchestra BioMed Holdings, Inc. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Orchestra BioMed Holdings, Inc. Ordinary Shares reported EPS of -$0.40, beating estimates by 9.83%, and revenue of $861.00K, 11.42% above expectations.

How did the market react to Orchestra BioMed Holdings, Inc. Ordinary Shares's Q3 2025 earnings?

The stock price moved up 8.47%, changed from $3.78 before the earnings release to $4.10 the day after.

When is Orchestra BioMed Holdings, Inc. Ordinary Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Orchestra BioMed Holdings, Inc. Ordinary Shares's next earnings report?

Based on -- analysts, Orchestra BioMed Holdings, Inc. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.